QYResearch is a leading market research publisher which pursuits high product quality with the belief that quality is the soul of business and consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience.

Los Angeles, CA -- (SBWire) -- 11/30/2018 --CIPN is a common adverse effect of several cancer therapies including taxanes and platinum drugs. Symptoms include decreased sensation and tingling of the hands and feet, severe pain, numbness and muscle weakness, all of which can occur during cancer treatment, and frequently persist after chemotherapy has ended.

The classification of Chemotherapy Induced Peripheral Neuropathy Treatment includes Calcium channel ?2-delta ligands, Antidepressants, Opioids and Other Drugs. And the proportion of Opioids in 2017 is about 27%, and the proportion is in decreasing trend from 2013 to 2017.

Chemotherapy Induced Peripheral Neuropathy Treatment is widely used for CIPN cause by Platinum Agents, Taxanes, Vinca Alkaloids and Others. The most proportion of Chemotherapy Induced Peripheral Neuropathy Treatment is used in Platinum Agents, and the proportion in 2017 is 42%.

North America is the largest sales place, with a sales market share nearly 41% in 2017. Following North America, Europe is the second largest sales place with the sales market share of 27%.

In 2018, the global Chemotherapy Induced Peripheral Neuropathy Treatment market size was 1300 million US$ and is forecast to 2150 million US in 2025, growing at a CAGR of 6.5% from 2018. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Chemotherapy Induced Peripheral Neuropathy Treatment.

This study researches the market size of Chemotherapy Induced Peripheral Neuropathy Treatment, presents the global Chemotherapy Induced Peripheral Neuropathy Treatment sales and revenue by companies, regions, type and application, history breakdown data from 2013 to 2018, and forecast to 2025.

This report focuses on the key data information of Chemotherapy Induced Peripheral Neuropathy Treatment in key regions like North America, Europe, Asia Pacific, Central & South America, and Middle East & Africa, presents sales, revenue, market share, growth rate of Chemotherapy Induced Peripheral Neuropathy Treatment for each region and countries in each region.

Request Sample Report Copy@ https://www.qyresearch.com/sample-form/form/797537/global-chemotherapy-induced-peripheral-neuropathy-treatment-industry-research-report-growth-trends-and-competitive-analysis

For top companies, this report investigates and analyzes the sales, revenue, market share and growth rate for the top players, key data from 2013 to 2018.

This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

This report includes the following manufacturers; we can also add the other companies as you want.

Aptinyx

Asahi Kasei Pharma

Regenacy Pharmaceuticals

MAKScientific

Metys Pharmaceuticals

Nemus Bioscience

PledPharma

Sova Pharmaceuticals

DermaXon

Immune Pharmaceuticals

Kineta

Krenitsky Pharmaceuticals

PeriphaGen

Apexian Pharma

WinSanTor

Solasia Pharma

Market Segment by Product Type

Calcium Channel ?2-delta Ligands

Antidepressants

Opioids

Others

Market Segment by Application

Platinum Agents

Taxanes

Vinca Alkaloids

Others

Buy Full market Report Now, Report delivery time within 24 hours @ https://www.qyresearch.com/settlement/pre/6e245d58a6314bc243c84fb1a83689ae,0,1,Global%20Chemotherapy%20Induced%20Peripheral%20Neuropathy%20Treatment%20Industry%20Research%20Report%252C%20Growth%20Trends%20and%20Competitive%20Analysis%202018-2025

About QYResearch
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.